Blood. 2019 Nov 13;134(Supplement_1):20. doi: 10.1182/blood-2019-128403.

Deep Profiling of Genetic Aberrations and Clonal Evolution in Follicular Lymphoma.

Bai B^1,², Vodák D^3,^4,⁵, Nakken S^3,^4,^5,⁶, Wise JF^3,^7,⁸, Blaker YN^2,⁸, Lingjærde OC^2,^5,⁹, Brodtkorb M¹⁰, Hilden V^7,⁸, Trøen G¹¹, Lorenz S^3,¹², Lawrence MS^13,¹⁴, Myklebost O^3,^4,¹⁵, Meza-Zepeda L^3,^4,¹², Beiske K¹¹, Hovig E^3,^4,⁵, Smeland EB^2,^3,⁸, Holte H^2,^3,¹⁰, Myklebust JH^2,⁸.

1: Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, OSLO, Norway.
2: KG. Jebsen Centre for B cell malignancies, University of Oslo, Oslo, Norway.
3: Norwegian Cancer Genomics Consortium, Oslo, Norway.
4: Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
5: Department of Informatics, University of Oslo, Oslo, Norway.
6: Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
7: KG. Jebsen Centre for B cell Malignancies, University of Oslo, Oslo, Norway.
8: Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
9: Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
10: Department of Oncology, Oslo University Hospital, Oslo, Norway.
11: Department of Pathology, Oslo University Hospital, Oslo, Norway.
12: Genomics Core Facility, Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
13: Broad Institute of Harvard and MIT, Cambridge, MA.
14: Massachusetts General Hospital Cancer Center and Department of Pathology, Harvard Medical School, Charlestown, MA.
15: Department for Clinical Science, University of Bergen, Bergen, Norway.